In non-small cell lung cancer (NSCLC) A549 cell line, CD133+CXCR4+ cells had a stronger migration ability, higher expression of Vimentin (one of the mesenchymal phenotypes) and lower expression of E-cadherin (one of the epithelial phenotypes) than CD133+CXCR4-104. This evidence concerns the gene CDH1 and non-small cell lung carcinoma.